42 hospitals sue HHS for delayed Medicare DSH payments

The latest stories trending on MedCity News.

Editor's Pick

Top Story 42 Hospitals Sue HHS for 'Tens of Millions' of Dollars in Delayed Medicare DSH Payments Forty-two safety net hospitals recently sued HHS, alleging that the Medicare program "unlawfully withheld and unreasonably denied" DSH payments for decades. The plaintiff hospitals said that HHS' failure to recalculate DSH payments have cost them "tens of millions of dollars in funds that should have been paid to them many years ago." Network with the Best in Healthcare and Save $600 Now that spring has officially arrived, it's time to get out and network with the best of the best in 5-star luxury and convenience. Register Today and Save $600!

Featured News

Why Advances in Imaging Will Revolutionize the Way We Detect and Treat Disease Recently, scientists shared new findings that may indicate the inner core of the earth has […] FDA Approves Incyte Drug for Rare Skin Cancer Merkel Cell Carcinoma Regulatory approval of Incyte's cancer immunotherapy, Zynyz, comes two years after the FDA rejected an application seeking approval in a rare type of anal cancer. The decision makes the new Incyte drug the third approved treatment for metastatic Merkel cell carcinoma. Is There a Mental Health Disconnect Between Employers and Employees? Experts Weigh In Research shows that about 73% of benefits leaders believe their companies have increased mental health support, but about 40% of employees either don't believe or are unsure if their company promotes a healthy workplace. When it comes to if there's a disconnect between employers and employees in mental health, the issue often lies in communication, said Adam Stavisky, senior vice president of US benefits at Walmart. AppliedVR Earns First Unique CMS Code Ever Granted to a Digital Therapeutic CMS recently established a unique code for AppliedVR's flagship product, marking the first time a digital therapeutic or immersive therapeutic has ever been placed in an existing benefit category. The eight-week program is a physician-prescribed solution that allows patients to manage their chronic lower back pain without opioids from the comfort of their own home. Maven Clinic Expands Presence in UK With Acquisition of Naytal Through Maven's acquisition, Naytal's over 50 providers will join Maven's platform, more than doubling the company's number of providers in the U.K. Maven will also be able to sign on additional U.K.-based clients. NASH Drug Biotech 89bio Nails Phase 2 Goals; Next Up Is a Pivotal Clinical Trial 89bio reported its NASH drug candidate met the main endpoints of a mid-stage clinical trial. In addition to demonstrating efficacy and safety according to measures the FDA says are needed to support a regulatory submission, 89bio says the results also show its drug could offer a dosing edge over potential rivals.

Resources

10 Ways to Decode Silicon Valley Bank Collapse Shared with you in the form of 10 questions to encourage probing further into what happened and how it could have been prevented. Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe